Valley Cottage, NY — 02/15/2018 — Demand for tissue paper converting machines is directly dependent on the demand for tissue paper products. Global sales of tissue paper converting machines was valued at US$ 1,123.8 Mn in 2016, and is expected to reach US$ 1,912.6 Mn by the end of 2027, expanding at a CAGR of 5.0% during the forecast period. Investment in new machinery to support brand building and evolution of automation and technology are two primary reasons that are responsible for the growth of the global tissue paper converting machines market. Interesting insights on the global tissue paper converting machines market have been presented in a new report published by Future Market Insights titled “Tissue Paper Converting Machines Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2027).”
Global Tissue Paper Converting Machines Market: Trends
Advancement in rewinding technology to enhance the pace of tissue paper conversion and reduction in waste
Preference of customised machines over standard solutions
Prevalence of low end machines with low capacity levels in developing markets
Growing implementation of data exchange technologies to incorporate high automation levels
Global Tissue Paper Converting Machines Market: Forecast by System
On the basis of system, the global tissue paper converting machines market is segmented into toilet rolls lines, kitchen rolls lines, tissue fold lines, paper napkin lines, and standalone system. Toilet paper rolls account for more than half of the global tissue paper converting machines market, in which around 80% comprises the consumer market. In terms of value, the standalone segment accounts for 6.6% of the market share, while in terms of volume it accounts for 10% of the global market. The small players of Asia Pacific generally incorporate very low capacity integrated converting lines that also cost much lesser than the machines generally used by large tissue paper products manufacturers of North America.
Global Tissue Paper Converting Machines Market: Forecast by Operation
On the basis of operations, the global tissue paper converting machines market is segmented into fully automatic and semi-automatic. Due to low capital investment capability of small and regional tissue paper products manufacturers, the semi-automatic machines market accounts for around 10% of the global market. All the folded tissues and paper napkin converting machines are automatic, while toilet rolls and kitchen rolls converting machines have wide variations in automation.
Global Tissue Paper Converting Machines Market: Forecast by Region
China and Europe are currently the dominant regions in the global tissue paper converting machines market. China is further estimated to increase its market share in the coming years. APECJ is the fastest growing region due to a large number of developing countries and increasing demand for tissue paper products. The entire Asia Pacific market is composed of a large number of small and regional manufacturers of tissue paper products while North America accounts for the least number of manufacturers.
Global Tissue Paper Converting Machines Market: Key Players
Fabio Perini S.p.A., Paper Converting Machine Company Italia S.p.A., Omet S.R.L., Kawanoe Zoki Co., Ltd., Mtorres Disenos Industriales Sau, BaoSuo Paper Machinery Manufacture Co., Ltd., A.Celli Group, United Converting S.R.L., Futura S.p.A., Dechangyu Paper Machinery Manufacture Co., Ltd., Gambini S.p.A, C.G. Bretting Manufacturing Co. Inc., Wangda Industrial Co., Limited, Zambak Kagit San.Ve Tic.Ltd.Sti., Unimax Group Engineering & Development Corporation, Tissuewell S.R.L., 9. Septembar- Tissue Converting D.O.O., Maflex S.R.L., Hinnli Co., Ltd. and Chan Li Machinery Co., Ltd. are some of the top manufacturers in the global tissue paper converting machines market.
Latest posts by Maria Burns (see all)
- Magna Announces Fourth Quarter and 2017 Results and Raises Quarterly Cash Dividend by 20% - February 22, 2018
- Leading Token Venture Investor, Multicoin Capital Partners With Apex Token Fund for Upcoming ICO - February 22, 2018
- Novo Nordisk successfully completes the first phase 3a trial, PIONEER 1, with oral semaglutide - February 22, 2018